On last Friday, Cipla finally managed to traverse through a neckline resistance of ‘Inverse Head and Shoulder’ pattern around Rs 960 on a closing basis. In addition, the positive placement of ‘RSI-Smoothened’ is likely to provide the much-needed impetus for the next leg of the rally

Top 10 trading ideas for next 3-4 weeks as Nifty continues uptrend despite volatility

As long as the Nifty trades above 15,500, one should continue to trade with a positive bias and look for stock-specific buying opportunities during the week, says Ruchit Jain, of 5paisa.com

Analysts initiate coverage on 5 stocks with buy rating, expect 14-39 percent returns

Brokerages see opportunities in companies including Star Health, Data Patterns, Cipla, Aditya Birla Capital and KPIT Technologies

Trade Spotlight | What should investors do with GNFC, BGR Energy, Laurus Labs, Cipla and Gujarat Ambuja Exports today?

GNFC is in strong uptrend across all timeframes forming a series of higher tops and bottoms. The stock is well-placed above the 20, 50, 100 and 200-day SMA which reconfirmed bullish trend.

Trade Spotlight | What should you do with Sharda Cropchem, Bandhan Bank, Lupin, Cipla, Global Education?

Here's what Malay Thakkar of GEPL Capital, suggests investors possessing these stocks when the market resumes trading today

Hot Stocks | Here's why you should bet on Cipla, Coforge in near term

Traders are advised to stick to the stock centric approach because the real action lies there and we expect it to continue in coming session as well.

Trade Spotlight | What should you do with Future Retail, Cipla, Bajaj Finance, and SBI now?

Here's what Karan Pai of GEPL Capital, recommends investors should do with these stocks when the market resumes trading today.

Top 12 trading ideas from experts for the next 3-4 weeks as bears tighten grip

Traders are advised to stay light on positions and even if the market attempts to recover, one should avoid aggressive longs till the time 17,700 is not surpassed, says Sameet Chavan of Angel One.

Market at 3-month low. Top 10 trading ideas for the December series

Experts feel the mood at street turned more cautious and nervous after Friday's sharp fall and hence the more correction can't be ruled out if the Nifty decisively breaks 17,000 mark in coming days.

Trade Spotlight | What should investors do with Indiabulls Housing Finance, Cipla, Meghmani Organics & BEML now?

Here's what Mehul Kothari of Anand Rathi Shares & Stock Brokers, recommends investors should do with these stocks when the market resumes trading today.

Nifty marches towards 17,000: Top 10 trading ideas by experts for September series

The only concern is the banking index, which has shown a relative underperformance. But this index is still in a consolidation phase, and there's a good probability of some buying interest emerging. This would further support the benchmark, says one analyst.

Hot Stocks | 'Can bet on Cipla, BPCL for short term'

"The immediate supports for Nifty are placed around 16,600 and 16,500 while the levels to watch on the upside will be 16,800 and then 17,000," said Ruchit Jain of Angel Broking.

Analysts suggest these 8 large-cap stocks to buy at this juncture, do you own any?

In these uncertain times, when markets are volatile as the country grapples with the frightening rise in COVID-19 infections, experts say investors should go for quality large-cap stocks and use any near-term correction to pick up such shares.

Budget 2021 | Focus on healthcare but mixed bag for pharma, 9 stocks you can pick from sector

The sector was in focus in Union Budget 2021. Finance Minister Nirmala Sitharaman in her Budget speech announced an outlay of Rs 2,23,846 crore for health and well being.

Hot Stocks | Tata Motors, Cummins India, Cipla can give up to 19% return in short-term

The key support levels for Nifty in the short-term are 13,750 which is a 61.8 percent retracement level of the rise from 13,131-14,753.

Analysts upgrade rating on these 9 stocks in December for up to 34% returns

On the long term, "the resumption of economic activity and the vaccination drive will dictate investor sentiment going forward, hence, we remain bullish on markets," Prashanth Tapse of Mehta Equities said.

Brokerages upgraded these 35 stocks in November; expect returns up to 40%

The most noted point after September quarter earnings season was that more than 100 stocks witnessed upgrade in rating to buy from brokerages.

Diwali picks: Build your portfolio with these 20 stocks for Samvat 2077

One should always avoid investing in bad quality businesses because as is said a rising tide lifts all the boats but the end outcome is always bad in investing if one ignores the quality aspect, Shailendra Kumar of Narnolia advised.

Nifty likely to see new high in Samvat 2077, bet on these 8 stock ideas

On the decisive crossing of 12,400 levels would lift the Nifty to 13,300 levels, said Shrikant Chouhan of Kotak Securities.

Good time to build a portfolio, brokerages pick 20 stocks for 13-49% return

With midcaps and smallcaps expected to outperform largecaps, especially after September quarter earnings, this is the right time to build a portfolio, analysts have said.

'Expect a tepid start for Nifty on Monday; but these 3 bets can return 11-12%'

The volatility index IndiaVIX is hovering below 25 levels from the past couple of weeks which hints of no major movement in the short term.

Uncertainty likely to prevail, 10 bluechips that analysts and brokerages are betting on

SBI's economists say the surge in equity markets is not linked to economic recovery and maybe a sign of irrational exuberance.

Pharma: Is the show over or are there some fireworks left?

After some tough years, the pharma sector is performing well and is around 25 percent up while the broader market is down 20 percent year-to-date.

Pockets of opportunity: Analysts pick 12 midcap stocks with one-year horizon

The road ahead for the market is bumpy and a lot will depend on the course of coronavirus pandemic. Moreover, global cues and measures of governments and central banks will remain important factors for the market.

Monsoon to bring relief amid COVID-19 pain; 9 stocks that could benefit

Experts point out that the rabi season ended largely on expected lines and at present, it appears the kharif crop is unlikely to be affected and may see a normal season.